Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

Clinical trial NCT00722228 · RECRUITING

Trial details

NCT number: NCT00722228
Sponsor: Hadassah Medical Organization
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Ovarian Cancer Gastric Cancer Breast Cancer Lung Cancer Kidney Cancer Melanoma

Start date: 2008-07-01
Primary completion: 2025-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.